Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial
about
Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countriesComparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesCardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE)Drug interactions and antiretroviral drug monitoring.48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimensInduction with lopinavir-based treatment followed by switch to nevirapine-based regimen versus non-nucleoside reverse transcriptase inhibitors-based treatment for first line antiretroviral therapy in HIV infected children three years and older.Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapineNevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials.Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan.Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis.Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment serviceLow-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP.First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting.Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.HIV-1 drug-resistant minority variants: sweating the small stuffAntiretroviral therapy and tuberculosis: does the regimen matter?
P2860
Q27001286-F0EEDDDE-58B2-476A-806E-A2FC4AECC627Q28539169-479EBE25-A5CF-453E-B8E2-44D9155F8891Q33944936-9338A963-6921-4005-B4C7-8DF5A8F3E7B0Q34021173-6F384DBC-EB1D-4C9B-8A94-900C308C1278Q34134900-4C097EA3-5358-4998-8FC3-2D505CC74542Q34137798-549B9D44-CEC4-40FE-881A-2E3F7A44FF64Q34215346-E70DD64E-D315-4B1E-86CD-CC304B5ED1F4Q34250879-D7100AA5-ADD1-4D46-8DEC-5AC8B030ECC1Q35014739-E17F2826-C1C1-447C-9C11-0C70278A17F7Q35037738-2DF3EF94-C651-46D5-9611-76D8BCFA2483Q35942341-48CCC000-4834-4AB3-95D5-775FE15F87D9Q36343668-F6E57EC2-CF1E-4B14-ABF5-AF5173F04DEAQ36769221-D953A5E9-61C8-4837-9281-F579EBE7C5BDQ36852619-050A785A-7BB0-4B9B-A9D6-027426C5E9FAQ36933330-60BB49B2-D623-4F4E-8720-1A75E3084B4DQ37284765-18F37712-7795-481F-93B7-E68E4A3339CEQ37582339-9471E9F7-5DF2-4FD4-96A4-DC1D2750B922Q37732266-A53618DD-3EFC-468C-87D5-8E9AC16F58F3Q38811335-129FF684-D5EC-4B1C-929F-B83C4C5CE99BQ39648148-65CB78A9-DB0D-4C9A-B62D-EFF493288B7BQ42532116-784870C1-DBC8-477F-859F-38A36F7BE2EFQ45181697-D4BE8438-E594-4C96-9803-77F7F8E7AC0D
P2860
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@ast
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@en
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@nl
type
label
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@ast
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@en
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@nl
prefLabel
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@ast
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@en
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@nl
P2093
P2860
P1433
P1476
Nevirapine- versus lopinavir/r ...... in Africa: a randomized trial
@en
P2093
Aida Asmelash
Beverly Alston-Smith
Douglas Shaffer
Elias Halvas
Evelyn Hogg
Farida Amod
Francis Ssali
James McIntyre
John Mellors
P2860
P304
P356
10.1371/JOURNAL.PMED.1001236
P407
P577
2012-01-01T00:00:00Z